Congenital adrenal hyperplasia and P450 oxidoreductase deficiency

Clinical Endocrinology

Volumn 66, Issue 2, 2007, Pages 162-172

  Krone, Nils ^a   Dhir, Vivek ^a   Ivison, Hannah E ^a   Arlt, Wiebke ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; CYTOCHROME P450 REDUCTASE; OXIDOREDUCTASE; SEX HORMONE; STEROID 11BETA MONOOXYGENASE; STEROID 17ALPHA MONOOXYGENASE; STEROID 21 MONOOXYGENASE;

ANDROGEN BLOOD LEVEL; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY; ENZYME DEFECT; ENZYME DEFICIENCY; GENE LOCUS; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HORMONE DEFICIENCY; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SKELETON MALFORMATION; STEROID 11BETA MONOOXYGENASE DEFICIENCY; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROIDOGENESIS; VIRILIZATION;

ADRENAL HYPERPLASIA, CONGENITAL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENOTYPE; HUMANS; MALE; MUTATION; PHENOTYPE; VIRILISM;

EID: 33846214395     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02740.x     Document Type: Review

References (92)

1. White, P.C. & Speiser, P.W. (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews, 21, 245-291.
2. Merke, D.P. & Bornstein, S.R. (2005) Congenital adrenal hyperplasia. Lancet, 365, 2125-2136.
3. Ogilvie, C.M., Crouch, N.S., Rumsby, G., Creighton, S.M., Liao, L.-M. & Conway, G.S. (2006) Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues. Clinical Endocrinology, 64, 2-11.
4. Speiser, P.W., Dupont, B., Rubinstein, P., Piazza, A., Kastelan, A. & New, M.I. (1985) High frequency of nonclassical steroid 21-hydroxylase deficiency. American Journal of Human Genetics, 37, 650-667.
5. Peterson, R.E., Imperato-McGinley, J., Gautier, T. & Shackleton, C. (1985) Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. New England Journal of Medicine, 313, 1182-1191.
6. Adachi, M., Tachibana, K., Asakura, Y., Suwa, S. & Nishimura, G. (1999) A male patient presenting with major clinical symptoms of glucocorticoid deficiency and skeletal dysplasia, showing a steroid pattern compatible with 17alpha-hydroxylase/17,20-lyase deficiency, but without obvious CYP17 gene mutations. Endocrine Journal, 46, 285-292.
7. Reardon, W., Smith, A., Honour, J.W., Hindmarsh, P., Das, D., Rumsby, G., Nelson, I., Malcolm, S., Ades, L., Sillence, D., Kumar, D., DeLozier-Blanchet, C., McKee, S., Kelly, T., McKeehan, W.L., Baraitser, M. & Winter, R.M. (2000) Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? Journal of Medical Genetics, 37, 26-32.
8. Arlt, W., Walker, E.A., Draper, N., Ivison, H.E., Ride, J.P., Hammer, F., Chalder, S.M., Borucka-Mankiewicz, M., Hauffa, B.P., Malunowicz, E.M., Stewart, P.M. & Shackleton, C.H. (2004) Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet, 363, 2128-2135.
9. Fluck, C.E., Tajima, T., Pandey, A.V., Arlt, W., Okuhara, K., Verge, C.F., Jabs, E.W., Mendonca, B.B., Fujieda, K. & Miller, W.L. (2004) Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nature Genetics, 36, 228-230.
10. Pang, S. & Shook, M.K. (1997) Current status of neonatal screening for congenital adrenal hyperplasia. Current Opinion in Pediatrics, 9, 419-423.
11. Thilen, A., Nordenstrom, A., Hagenfeldt, L., von Dobeln, U., Guthenberg, C. & Larsson, A. (1998) Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics, 101, E11.
12. Therrell, B.L. (2001) Newborn screening for congenital adrenal hyperplasia. Endocrinology and Metabolism Clinics of North America, 30, 15-30.
13. Steigert, M., Schoenle, E.J., Biason-Lauber, A. & Torresani, T. (2002) High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland. Journal of Clinical Endocrinology and Metabolism, 87, 4106-4110.
14. Olgemoller, B., Roscher, A.A., Liebl, B. & Fingerhut, R. (2003) Screening for congenital adrenal hyperplasia: adjustment of 17- hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. Journal of Clinical Endocrinology and Metabolism, 88, 5790-5794.
15. Speiser, P.W. & White, P.C. (2003) Congenital adrenal hyperplasia. New England Journal of Medicine, 349, 776-788.
16. Jaaskelainen, J., Tiitinen, A. & Voutilainen, R. (2001) Sexual function and fertility in adult females and males with congenital adrenal hyperplasia. Hormone Research, 56, 73-80.
17. Pang, S., Hotchkiss, J., Drash, A.L., Levine, L.S. & New, M.I. (1977) Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 45, 1003-1008.
18. Clayton, P.E., Miller, W.L., Oberfield, S.E., Ritzen, E.M., Sippell, W.G. & Speiser, P.W. (2002) Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Hormone Research, 58, 188-195.
19. Joint LWPES/ESPE CAH Working Group (2002) Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Journal of Clinical Endocrinology and Metabolism, 87, 4048-4053.
20. Balsamo, A., Cacciari, E., Piazzi, S., Cassio, A., Bozza, D., Pirazzoli, P. & Zappulla, F. (1996) Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-95. Pediatrics, 98, 362-367.
21. Nordenstrom, A., Ahmed, S., Jones, J., Coleman, M., Price, D.A., Clayton, P.E. & Hall, C.M. (2005) Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening. Hormone Research, 63, 22-28.
22. Payne, A.H. & Hales, D.B. (2004) Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocrine Reviews, 25, 947-970.
23. Carroll, M.C., Campbell, R.D. & Porter, R.R. (1985) Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proceedings of the National Academy of Sciences of the USA, 82, 521-525.
24. White, P.C., Grossberger, D., Onufer, B.J., Chaplin, D.D., New, M.I., Dupont, B. & Strominger, J.L. (1985) Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proceedings of the National Academy of Sciences of the USA, 82, 1089-1093.
25. White, P.C., New, M.I. & Dupont, B. (1986) Structure of human steroid 21-hydroxylase genes. Proceedings of the National Academy of Sciences of the USA, 83, 5111-5115.
26. Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O. & Fujii-Kuriyama, Y. (1986) Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proceedings of the National Academy of Sciences of the USA, 83, 2841-2845.
27. Speiser, P.W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M.T., Lesser, M., New, M.I. & White, P.C. (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Investigation, 90, 584-595.
28. Wedell, A., Thilen, A., Ritzen, E.M., Stengler, B. & Luthman, H. (1994) Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. Journal of Clinical Endocrinology and Metabolism, 78, 1145-1152.
29. Jaaskelainen, J., Levo, A., Voutilainen, R. & Partanen, J. (1997) Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. Journal of Clinical Endocrinology and Metabolism, 82, 3293-3297.
30. Krone, N., Braun, A., Roscher, A.A., Knorr, D. & Schwarz, H.P. (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. Journal of Clinical Endocrinology and Metabolism, 85, 1059-1065.
31. Stikkelbroeck, N.M., Hoefsloot, L.H., de Wijs, I.J., Otten, B.J., Hermus, A.R. & Sistermans, E.A. (2003) CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations. Journal of Clinical Endocrinology and Metabolism, 88, 3852-3859.
32. Zachmann, M., Tassinari, D. & Prader, A. (1983) Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients. Journal of Clinical Endocrinology and Metabolism, 56, 222-229.
33. White, P.C., Curnow, K.M. & Pascoe, L. (1994) Disorders of steroid 11 beta-hydroxylase isozymes. Endocrine Reviews, 15, 421-438.
34. Peter, M. (2002) Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency. Seminars in Reproductive Medicine, 20, 249-254.
35. Rosler, A., Leiberman, E. & Cohen, T. (1992) High frequency of congenital adrenal hyperplasia (classic 11 beta-hydroxylase deficiency) among Jews from Morocco. American Journal of Medical Genetics, 42, 827-834.
36. Joehrer, K., Geley, S., Strasser-Wozak, E.M., Azziz, R., Wollmann, H.A., Schmitt, K., Kofler, R. & White, P.C. (1997) CYP11B1 mutations causing non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Human Molecular Genetics, 6, 1829-1834.
37. Azziz, R., Boots, L.R., Parker, C.R. Jr, Bradley, E. Jr & Zacur, H.A. (1991) 11 beta-hydroxylase deficiency in hyperandrogenism. Fertility and Sterility, 55, 733-741.
38. Mornet, E., Dupont, J., Vitek, A. & White, P.C. (1989) Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450 (11) beta). Journal of Biological Chemistry, 264, 20961-20967.
39. Curnow, K.M., Slutsker, L., Vitek, J., Cole, T., Speiser, P.W., New, M.I., White, P.C. & Pascoe, L. (1993) Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proceedings of the National Academy of Sciences of the USA, 90, 4552-4556.
40. Geley, S., Kapelari, K., Johrer, K., Peter, M., Glatzl, J., Vierhapper, H., Schwarz, S., Helmberg, A., Sippell, W.G., White, P.C. & Kofler, R. (1996) CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta- hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 81, 2896-2901.
41. White, P.C., Dupont, J., New, M.I., Leiberman, E., Hochberg, Z. & Rosler, A. (1991) A mutation in CYP11B1 (Arg-448-His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin. Journal of Clinical Investigation, 87, 1664-1667.
42. Helmberg, A., Ausserer, B. & Kofler, R. (1992) Frame shift by insertion of 2 basepairs in codon 394 of CYP11B1 causes congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 75, 1278-1281.
43. Naiki, Y., Kawamoto, T., Mitsuuchi, Y., Miyahara, K., Toda, K., Orii, T., Imura, H. & Shizuta, Y. (1993) A nonsense mutation (TGG [Trp116] →TAG [Stop]) in CYP11B1 causes steroid 11 beta-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 77, 1677-1682.
44. Skinner, C.A. & Rumsby, G. (1994) Steroid 11 beta-hydroxylase deficiency caused by a five base pair duplication in the CYP11B1 gene. Human Molecular Genetics, 3, 377-378.
45. Yang, L.X., Toda, K., Miyahara, K., Nomoto, S., Kinoshita, E., Baba, T., Yoshimoto, M., Araki, K., Kurashige, T., Hashimoto, K. & et al. (1995) Classic steroid 11 beta-hydroxylase deficiency caused by a C→G transversion in exon 7 of CYP11B1. Biochemical and Biophysical Research Communications, 216, 723-728.
46. Nakagawa, Y., Yamada, M., Ogawa, H. & Igarashi, Y. (1995) Missense mutation in CYP11B1 (CGA [Arg-384]→GGA [Gly]) causes steroid 11 beta-hydroxylase deficiency. European Journal of Endocrinology, 132, 286-289.
47. Merke, D.P., Tajima, T., Chhabra, A., Barnes, K., Mancilla, E., Baron, J. & Cutler, G.B. Jr (1998) Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11{beta}-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 270-273.
48. Zhu, Y.S., Cordero, J.J., Can, S., Cai, L.Q., You, X., Herrera, C., DeFillo-Ricart, M., Shackleton, C. & Imperato-McGinley, J. (2003) Mutations in CYP11B1 gene: phenotype-genotype correlations. American Journal of Medical Genetics, 122A, 193-200.
49. Krone, N., Riepe, F.G., Gotze, D., Korsch, E., Rister, M., Commentz, J., Partsch, C.J., Grotzinger, J., Peter, M. & Sippell, W.G. (2005) Congenital adrenal hyperplasia due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three-base pair deletion in the CYP11B1 gene. Journal of Clinical Endocrinology and Metabolism, 90, 3724-3730.
50. Krone, N., Grischuk, Y., Muller, M., Volk, R.E., Grotzinger, J., Holterhus, P.M., Sippell, W.G. & Riepe, F.G. (2006) Analyzing the functional and structural consequences of two point mutations (P94L and A368D) in the CYP11B1 gene causing congenital adrenal hyperplasia resulting from 11-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 91, 2682-2688.
51. 4 isomerase gene family. Endocrine Reviews, 26, 525-582.
52. Lutfallah, C., Wang, W., Mason, J.I., Chang, Y.T., Haider, A., Rich, B., Castro-Magana, M., Copeland, K.C., David, R. & Pang, S. (2002) Newly proposed hormonal criteria via genotypic proof for type II, 3β- hydroxysteroid dehydrogenase deficiency. Journal of Clinical Endocrinology and Metabolism, 87, 2611-2622.
53. Mermejo, L.M., Elias, L.L.K., Marui, S., Moreira, A.C., Mendonca, B.B. & de Castro, M. (2005) Refining hormonal diagnosis of type II, 3β-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping. Journal of Clinical Endocrinology and Metabolism, 90, 1287-1293.
54. Yanase, T., Simpson, E.R. & Waterman, M.R. (1991) 17 alpha-hydroxylase/ 17,20-lyase deficiency: from clinical investigation to molecular definition. Endocrine Reviews, 12, 91-108.
55. New, M.I. (1970) Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. Journal of Clinical Investigation, 49, 1930-1941.
56. Matsuzaki, S., Yanase, T., Murakami, T., Uehara, S., Nawata, H. & Yajima, A. (2000) Induction of endometrial cycles and ovulation in a woman with combined 17α-hydroxylase/17,20-lyase deficiency due to compound heterozygous mutations on the p45017α gene. Fertility and Sterility, 73, 1183-1186.
57. Miura, K., Yasuda, K., Yanase, T., Yamakita, N., Sasano, H., Nawata, H., Inoue, M., Fukaya, T. & Shizuta, Y. (1996) Mutation of cytochrome P-45017 alpha gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17. Journal of Clinical Endocrinology and Metabolism, 81, 3797-3801.
58. Auchus, R.J. (2001) The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinology and Metabolism Clinics of North America, 30, 101-119. vii.
59. Biglieri, E.G., Herron, M.A. & Brust, N. (1966) 17-hydroxylation deficiency in man. Journal of Clinical Investigation, 45, 1946-1954.
60. Geller, D.H., Auchus, R.J., Mendonca, B.B. & Miller, W.L. (1997) The genetic and functional basis of isolated 17,20-lyase deficiency. Nature Genetics, 17, 201-205.
61. Biason-Lauber, A., Leiberman, E. & Zachmann, M. (1997) A single amino acid substitution in the putative redox partner-binding site of P450c17 as cause of isolated 17,20-lyase deficiency. Journal of Clinical Endocrinology and Metabolism, 82, 3807-3812.
62. Sherbet, D.P., Tiosano, D., Kwist, K.M., Hochberg, Z. & Auchus, R.J. (2003) CYP17 Mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding. Journal of Biological Chemistry, 278, 48563-48569.
63. Miller, W.L. (2005) Minireview: regulation of steroidogenesis by electron transfer. Endocrinology, 146, 2544-2550.
64. Auchus, R.J., Lee, T.C. & Miller, W.L. (1998) Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. Journal of Biological Chemistry, 273, 3158-3165.
65. Geller, D.H., Auchus, R.J. & Miller, W.L. (1999) P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5. Molecular Endocrinology, 13, 167-175.
66. Shackleton, C. & Malunowicz, E. (2003) Apparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome. Steroids, 68, 707-717.
67. Shackleton, C., Marcos, J., Malunowicz, E.M., Szarras-Czapnik, M., Jira, P., Taylor, N.F., Murphy, N., Crushell, E., Gottschalk, M., Hauffa, B., Cragun, D.L., Hopkin, R.J., Adachi, M. & Arlt, W. (2004) Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis. American Journal of Medical Genetics, 128A, 223-231.
68. Adachi, M., Asakura, Y., Tachibana, K. & Shackleton, C. (2004) Abnormal steroidogenesis in three patients with Antley-Bixler syndrome: apparent decreased activity of 17α-hydroxylase, 17,20-lyase and 21-hydroxylase. Pediatrics International, 46, 583-589.
69. Kelley, R.I., Kratz, L.E., Glaser, R.L., Netzloff, M.L., Wolf, L.M. & Jabs, E.W. (2002) Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. American Journal of Medical Genetics, 110, 95-102.
70. Fukami, M., Hasegawa, T., Horikawa, R., Ohashi, T., Nishimura, G., Homma, K. & Ogata, T. (2006) Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis. Pediatric Research, 59, 276-280.
71. Shackleton, C., Marcos, J., Arlt, W. & Hauffa, B.P. (2004) Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype. American Journal of Medical Genetics, 129A, 105-112.
72. Cragun, D.L., Trumpy, S.K., Shackleton, C.H., Kelley, R.I., Leslie, N.D., Mulrooney, N.P. & Hopkin, R.J. (2004) Undetectable maternal serum uE3 and postnatal abnormal sterol and steroid metabolism in Antley-Bixler syndrome. American Journal of Medical Genetics, 129A, 1-7.
73. Fukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., Okuyama, T., Nakai, H., Soneda, S., Tachibana, K., Matsuo, N., Sato, S., Homma, K., Nishimura, G., Hasegawa, T. & Ogata, T. (2005) Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. Journal of Clinical Endocrinology and Metabolism, 90, 414-426.
74. Adachi, M., Tachibana, K., Asakura, Y., Yamamoto, T., Hanaki, K. & Oka, A. (2004) Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome. American Journal of Medical Genetics, 128A, 333-339.
75. Shen, A.L., O'Leary, K.A. & Kasper, C.B. (2002) Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. Journal of Biological Chemistry, 277, 6536-6541.
76. Otto, D.M., Henderson, C.J., Carrie, D., Davey, M., Gundersen, T.E., Blomhoff, R., Adams, R.H., Tickle, C. & Wolf, C.R. (2003) Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Molecular and Cellular Biology, 23, 6103-6116.
77. Huang, N., Pandey, A.V., Agrawal, V., Reardon, W., Lapunzina, P.D., Mowat, D., Jabs, E.W., Vliet, G.V., Sack, J., Fluck, C.E. & Miller, W.L. (2005) Diversity and function of mutations in p450 oxidoreductase in patients with antley-bixler syndrome and disordered steroidogenesis. American Journal of Human Genetics, 76, 729-749.
78. Adachi, M., Asakura, Y., Matsuo, M., Yamamoto, T., Hanaki, K. & Arlt, W. (2006) POR R457H is a global founder mutation causing Antley-Bixler syndrome with autosomal recessive trait. American Journal of Medical Genetics. Part A, 140, 633-635.
79. Chun, K., Siegel-Bartelt, J., Chitayat, D., Phillips, J. & Ray, P.N. (1998) FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. American Journal of Medical Genetics, 77, 219-224.
80. Tsai, F.J., Wu, J.Y., Yang, C.F. & Tsai, C.H. (2001) Further evidence that fibroblast growth factor receptor 2 mutations cause Antley-Bixler syndrome. Acta Paediatrica, 90, 595-597.
81. Wilkie, A.O., Slaney, S.F., Oldridge, M., Poole, M.D., Ashworth, G.J., Hockley, A.D., Hayward, R.D., David, D.J., Pulleyn, L.J., Rutland, P., Malcolm, S., Winter, R.M. & Reardon, W. (1995) Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genetics, 9, 165-172.
82. Jabs, E.W., Li, X., Scott, A.F., Meyers, G., Chen, W., Eccles, M., Mao, J.I., Charnas, L.R., Jackson, C.E. & Jaye, M. (1994) Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nature Genetics, 8, 275-279.
83. Reardon, W., Winter, R.M., Rutland, P., Pulleyn, L.J., Jones, B.M. & Malcolm, S. (1994) Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genetics, 8, 98-103.
84. Muenke, M., Schell, U., Hehr, A., Robin, N.H., Losken, H.W., Schinzel, A., Pulleyn, L.J., Rutland, P., Reardon, W., Malcolm, S. & Winter, R.M. (1994) A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genetics, 8, 269-274.
85. Wilkie, A.O., Patey, S.J., Kan, S.H., van den Ouweland, A.M. & Hamel, B.C. (2002) FGFs, their receptors, and human limb malformations: clinical and molecular correlations. American Journal of Medical Genetics, 112, 266-278.
86. Pursley, T.J., Blomquist, I.K., Abraham, J., Andersen, H.F. & Bartley, J.A. (1996) Fluconazole-induced congenital anomalies in three infants. Clinical Infectious Diseases, 22, 336-340.
87. Aleck, K.A. & Bartley, D.L. (1997) Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. American Journal of Medical Genetics, 72, 253-256.
88. Mann, R.K. & Beachy, P.A. (2004) Novel lipid modifications of secreted protein signals. Annual Review of Biochemistry, 73, 891-923.
89. Ehrmann, D.A. (2005) Polycystic ovary syndrome. New England Journal of Medicine, 352, 1223-1236.
90. Wilson, J.D., Auchus, R.J., Leihy, M.W., Guryev, O.L., Estabrook, R.W., Osborn, S.M., Shaw, G. & Renfree, M.B. (2003) 5α-Androstane-3α, 17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α,17α-diol-20-one as a key intermediate. Endocrinology, 144, 575-580.
91. 21 steroids are substrates for human cytochrome P450c17. Archives of Biochemistry and Biophysics, 418, 151-160.
92. Homma, K., Hasegawa, T., Nagai, T., Adachi, M., Horikawa, R., Fujiwara, I., Tajima, T., Takeda, R., Fukami, M. & Ogata, T. (2006) Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone. Journal of Clinical Endocrinology and Metabolism, 91, 2643-2649.